Imran Talat 4
4 · Rani Therapeutics Holdings, Inc. · Filed Mar 24, 2023
Insider Transaction Report
Form 4
Imran Talat
DirectorChief Executive Officer
Transactions
- Tax Payment
Class A Common Stock
2023-03-22$5.95/sh−7,988$47,529→ 90,945 total
Footnotes (2)
- [F1]Represents the number of shares withheld by and surrendered to the Issuer on March 22, 2023, to satisfy tax withholding obligations that arose in connection with the vesting of the restricted stock units granted to Mr. Imran on March 22, 2022.
- [F2]Includes 12,343 shares held by VH Moll, L.P. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.